Skip to content Skip to footer

Research Portal of the TU Dresden

Imatinib mesylate does not impair the immunogenicity of human myeloid blood dendritic cells

Research output: Contribution to journal › Letter › Contributed › peer-review

Contributors

R. Wehner - , Institute for Immunology (Author)
M. Wendisch - , Institute for Immunology (Author)
K. Schäkel - , Institute for Immunology (Author)
M. Bornhäuser - , Department of Internal Medicine I (Author)
U. Platzbecker - , Department of internal Medicine I (Author)
B. Mohr - , Department of Internal Medicine I (Author)
A. Temme - , Institute for Immunology (Author)
M. Bachmann - , Institute for Immunology (Author)
E. P. Rieber - , Institute for Immunology (Author)
M. Schmitz - , Institute for Immunology (Author)

Details

Original language	English
Pages (from-to)	1629-1632
Number of pages	4
Journal	Leukemia
Volume	20
Issue number	9
Publication status	Published - Sept 2006
Peer-reviewed	Yes

External IDs

PubMed	16838025
ORCID	/0000-0001-5084-1180/work/173988722

Keywords

Sustainable Development Goals

SDG 3 - Good Health and Well-being

ASJC Scopus subject areas